Description
A potent and selective CB1 receptor antagonist (Kis = 5.6 and >1,000 nM for CB1 and CB2, respectively); induces lipolysis, reduces hepatomegaly, decreases body weight, and improves dyslipidemia by reducing triglyceride, free fatty acid, and total cholesterol levels and by increasing HDL/LDL ratios in rodent models; elicits antiproliferative and immunomodulatory effects in vitro,
Formal name: 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide
Synonyms: SR141716
Molecular weight: 463.8
CAS: 168273-06-1
Purity: ≥98%
Formulation: A crystalline solid